Release of histamine from mast cells by vasoactive peptides.
about
Arthritis and pain. Neurogenic origin of joint painCapsaicin evokes secretion of nasal fluid and depletes substance P and calcitonin gene-related peptide from the nasal mucosa in the ratContribution of B(2) receptors for bradykinin in arthus reaction-induced plasma extravasation in wild-type or B(2) transgenic knockout mice.Substance P recognition by a subset of human T lymphocytes.Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependentImmunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets.Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skinAcute effect of inhaled bradykinin on tracheobronchial clearance in normal humansRole of neurogenic inflammation in pancreatitis and pancreatic pain.Topical substance P increases inflammatory cell density in genetically diabetic murine wounds.Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflexTopical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin.Responses of dermal mast cells to injury.Further studies on histamine release from rat mast cells in vitro induced by peptides. Characteristics of a synthetic intermediate with potent releasing activity.Involvement of substance P present in primary afferent neurones in modulation of cutaneous blood flow in the instep of rat hind paw.The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response.Involvement of capsaicin-sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin.The capacity of basic peptides to trigger exocytosis from mast cells correlates with their capacity to immobilize band 3 proteins in erythrocyte membranes.The mechanism of action of a substance P antagonist (D-Pro2, D-Trp7,9)-SP.Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.Rat peritoneal mast cells release dipeptidyl peptidase IIIncreased permeability of microcarrier-cultured endothelial monolayers in response to histamine and thrombin. A model for the in vitro study of increased vasopermeabilityA comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release.Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rats.The effects of 5-HT on articular sensory receptors in normal and arthritic rats.Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist.Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition.
P2860
Q28210860-F1AEB9CF-30EA-483A-9FD1-B130C35969C0Q28340375-8D03AEE5-3979-4F56-B215-BEEF4DB1F8B9Q31667717-9CBEDD2B-44BC-426D-A2D7-46DB2712AC14Q34618387-32843DC5-E049-4ECC-8D7A-43AAFFA2DE98Q35816116-4609AEB6-2D48-4BDD-A3A9-98E5B3DA0792Q35925118-6ECB28BF-9055-4965-9B34-B819D7B50DCAQ36097423-F28A7E61-45DD-4C6E-A623-C48934D8590FQ36269465-2606DE6B-CF77-41BF-86A1-99669BC598F7Q36281881-C628AA73-E935-4D58-889A-5321BB9CE838Q41174589-4B91DAEF-E746-4B41-8930-EDB3B7525AA3Q41246529-2F8CA33E-D63A-477A-8066-98053666A8E1Q41534244-A7CEF8BB-735C-42AC-AC6B-FFB6B4ADB225Q41822760-6858FCAF-285D-400B-B604-9661B265C03AQ41829187-2D4774C3-A90D-4774-9161-C30873E69FC7Q41834881-D8667032-0174-4541-8199-93A07D668513Q41852222-71663C61-E09E-44E6-9269-2BDE75D45EA0Q41862160-B0864AFA-8CF1-4276-B534-8CE4B8F70443Q41868665-890AEB61-935D-43A4-B828-98BC911ABFC4Q41984028-4B583F07-1938-42E7-B470-1EC37305B003Q41991407-81950FFE-6E9C-484B-90D6-5D4AC92CA63CQ42053339-164175BB-02E2-40D5-AB4E-D5F529CA230CQ42257089-2BE11991-656C-4486-911B-79D74D5E4103Q42263954-9D1F6528-3510-4E43-8CD3-CE6C991C77BDQ42329450-949850EC-EC13-4F7F-A5E1-B1D5D454FCE0Q42562469-45E43F7E-7F09-4EF9-BD5D-747DCCB8AF26Q42849951-5FB83091-1AC7-4F98-BB87-877FB462D319Q43260646-C2D745DB-EBA7-4C71-A000-9A9D387E53F3
P2860
Release of histamine from mast cells by vasoactive peptides.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh-hant
name
Release of histamine from mast cells by vasoactive peptides.
@en
Release of histamine from mast cells by vasoactive peptides.
@nl
type
label
Release of histamine from mast cells by vasoactive peptides.
@en
Release of histamine from mast cells by vasoactive peptides.
@nl
prefLabel
Release of histamine from mast cells by vasoactive peptides.
@en
Release of histamine from mast cells by vasoactive peptides.
@nl
P1476
Release of histamine from mast cells by vasoactive peptides.
@en
P2093
P304
P577
1973-04-01T00:00:00Z